1.
Int J Infect Dis
; 96: 567-569, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-526616
ABSTRACT
We report that patients with COVID-19 displaying distinct neurological disorders have undetectable or extremely low levels of SARS-CoV-2 RNA in the cerebrospinal fluid, indicating that viral clearance precede the neurological involvement. This finding points to the need for the development of more sensitive molecular tests and the investigation of other neurotropic pathogens to exclude concurrent neuroinfection.